Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: ATELERIX LIFE SCIENCES INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2023-09-14 to 2026-02-27
Current total value of award: $749000
Description: ATELERIX - THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO PLAN AND EXECUTE A PHASE 1A CLINICAL TRIAL (HEREAFTER REFERRED TO AS THE ?PHASE 1A TRIAL?) OF THE NOVEL SMALL MOLECULE ATLX-0199 IN 30 NORMAL HEALTHY SUBJECTS. THE GOAL OF THE CLINICAL TRIAL IS